524661-BOM

Welcure Drugs & Pharmaceuticals Ltd.

BSE: 524661

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

0.25+0.0 (+0.00%)

17 Jul, 11:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

32.13

P/E (TTM)

P/B

0.33

P/S (TTM)

0.09

EV/EBITDA

CAPE (5Y)

ROE (TTM)

-5.50

ROCE (TTM)

-4.31

ROA (TTM)

-1.41

Avg 3Y ROE

-4.52

Earnings 3Y CAGR

-98.29

Sales 3Y CAGR

Sales 5Y CAGR

387.10

Debt/Equity

0.00

Consensus TP

Strong Buy %

Promoter Holding

Pledged %

Stock Analysis

Fundamental analysis overview of Welcure Drugs & Pharmaceuticals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 1388.95% for 12-month ended 31 Mar 2026 and the growth was 1377.72 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.23

Value 1388.95

-82.35114662

Low and declining Debt to Equity

The company has low Debt to Equity of 0.0 as on 31 Mar 2026 and Debt to Equity decreased by 1.2 in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -17.08% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low and declining ROE

The company reported low ROE of -5.5% for 12-month ended 31 Mar 2026 and ROE declined by -968 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of -1.9% for 12-month ended 31 Mar 2026 and operating margin declined by -544 bps from 1 year ago

What is Operating profit margin?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -258.1% for 12-month ended 31 Mar 2026 and the growth was 266.22 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Welcure Drugs & Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Welcure Drugs & Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Welcure Drugs & Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	14.12	14.12	14.12	14.12	14.12	14.12	14.12	14.12	14.12	14.12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Indian Promoter	14.12	14.12	14.12	14.12	14.12	14.12	14.12	14.12	14.12	14.12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	85.86	85.86	85.86	85.86	85.86	85.86	85.86	85.86	85.86	85.86	99.99	99.99	99.99	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
Bodies Corporate	9.82	9.81	9.81	9.81	9.81	9.81	8.39	7.73	7.86	6.98	3.79	3.60	3.45	3.45	3.45	3.45	3.64	3.84	3.82	0.92	0.68	0.72	4.57	2.15	2.10
Others (incl. Retail) No. of shareholders	76.04 16,490	76.05 16,567	76.05 16,473	76.05 16,447	76.05 16,450	76.05 16,432	77.47 17,290	78.13 18,818	78.00 18,859	78.88 20,371	96.20 24,609	96.39 28,982	96.54 28,923	96.55 29,162	96.55 29,502	96.55 29,866	96.36 31,439	96.16 30,954	96.18 30,130	99.08 30,515	99.32 32,278	99.28 37,209	95.43 76,838	97.85 87,174	97.90 87,861

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Welcure Drugs & Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Kifs Enterprise	23 Apr 2026	sell	₹ 0.31	69.77 lac	-
Share India Securities Limited	15 Apr 2026	sell	₹ 0.35	1.09 cr	-
Share India Securities Limited	15 Apr 2026	buy	₹ 0.35	1.09 cr	-
Satish Kumar Grandhi	15 Apr 2026	sell	₹ 0.34	82.90 lac	-
Share India Securities Limited	19 Mar 2026	sell	₹ 0.26	66.25 lac	-
Share India Securities Limited	19 Mar 2026	buy	₹ 0.25	59.26 lac	-
Share India Securities Limited	04 Mar 2026	sell	₹ 0.30	50.97 lac	-
Saroj Kumar Kundu	04 Mar 2026	buy	₹ 0.30	57.75 lac	-
Share India Securities Limited	04 Mar 2026	buy	₹ 0.30	73.31 lac	-
Saroj Kumar Kundu	04 Mar 2026	sell	₹ 0.29	81.17 lac	-

…

Corporate Actions

History of Welcure Drugs & Pharmaceuticals Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Stock Split1 : 10
Ex-date: 16th Oct 2025Announced on: 11th Aug 2025
Nominal value change from INR 10 to INR 1.
Bonus1 new shares for 10 existing shares
Ex-date: 16th Oct 2025Announced on: 11th Aug 2025
Dividend₹ 1/share
Record date: 17th Sep 1996Ex-date: 19th Aug 1996
Announced on: 7th Aug 1996
Dividend₹ 1/share
Record date: 25th Apr 1996Ex-date: 30th Apr 1996
Announced on: 22nd Mar 1996
Rights Issue(1 new shares @ ₹10 for 1 existing shares)
Ex-date: 1st Jan 1996Announced on: 22nd Dec 1995
Cum price is INR 16.5

Company Profile

Overview of Welcure Drugs & Pharmaceuticals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company operates in one segment, which is Dealing in medical products.

Key personnel

Mr. Chintan Didawala Ganpat

Chief Financial Officer, Managing Director

Ms. Rashi AggarwalD

Woman Director

Mr. Krishnan J. IyerD

Additional Non-Executive Non-Independent Director

Mr. Mohammad Faisal S ShaikhD

Additional Non-Executive Non-Independent Director

Mrs. Sitaben S. PatelD

Non-Executive Independent Director

Mr. Yogeshkumar PrajapatiD

Non-Executive Independent Director

Mr. Ravi ThakorD

Non-Executive Independent Director

Mr. Ravi ThakorD

Non-Executive Independent Director

View all

Incorporated on

06 Aug 1996

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

04 Aug 1994

Free Float

1,22,35,65,200

Website

https://welcuredrugs.com/

Phone no.

Address

33/36 Basement (Back side),, West Patel Nagar,, Near Ram Jass Ground, DELHI, 110008, India

Frequently Asked Questions

What is the current share price of Welcure Drugs & Pharmaceuticals Ltd.?

The current share price of Welcure Drugs & Pharmaceuticals Ltd. is ₹ 0.25 as of 17 Jul 2026.

What is the market capitalisation of Welcure Drugs & Pharmaceuticals Ltd.?

The market capitalisation of Welcure Drugs & Pharmaceuticals Ltd. stands at ₹ 32.13 Cr.

What is the PE ratio of Welcure Drugs & Pharmaceuticals Ltd.?

The Price-to-Earnings (PE) ratio of Welcure Drugs & Pharmaceuticals Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Welcure Drugs & Pharmaceuticals Ltd.?

Welcure Drugs & Pharmaceuticals Ltd. has a Return on Equity (ROE) of -5.50% and a Return on Capital Employed (ROCE) of -4.31% as per the latest financial reports.

What is the 52-week high and low of Welcure Drugs & Pharmaceuticals Ltd.?

The 52-week high of Welcure Drugs & Pharmaceuticals Ltd. is - and the 52-week low is -.

What is the dividend yield of Welcure Drugs & Pharmaceuticals Ltd.?

The dividend yield of Welcure Drugs & Pharmaceuticals Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Welcure Drugs & Pharmaceuticals Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 97.90% of Welcure Drugs & Pharmaceuticals Ltd. shares.

What sector does Welcure Drugs & Pharmaceuticals Ltd. belong to?

Welcure Drugs & Pharmaceuticals Ltd. operates in the Healthcare sector.

What is the beta of Welcure Drugs & Pharmaceuticals Ltd.?

The beta of Welcure Drugs & Pharmaceuticals Ltd. is 1.20, indicating its price volatility relative to the broader market. Over the past 1 year, Welcure Drugs & Pharmaceuticals Ltd. has delivered an absolute return of -76.79%.

What is the RSI of Welcure Drugs & Pharmaceuticals Ltd.?

The 14-day Relative Strength Index (RSI) of Welcure Drugs & Pharmaceuticals Ltd. is 47.01, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Welcure Drugs & Pharmaceuticals Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Welcure Drugs & Pharmaceuticals Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Corporate Actions